Pharmaceutical industry
Advanced Polymer Systems Expands Licensing Agreement with Dermik Laboratories
Advanced Polymer Systems, Inc. announced that its partner, Dermik Laboratories, Inc., has initiated Phase III studies of a product containing Microsponge(R)-entrapped 5-fluorouracil (5-FU) for the treatment of actinic keratosis, a common precancerous skin condition. The formulation utilizes Advanced Polymer's proprietary Microsponge technology to deliver 5-FU with